more

Merck & Co. (MRK)

(Delayed Data from NYSE)

$102.92 USD

+1.75 (1.73%)

Updated Nov 8, 2024 04:00 PM ET

After-Market: $103.13 +0.21 (0.20%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.10%
2	Buy	17.80%
3	Hold	9.50%
4	Sell	2.70%
5	Strong Sell	2.70%
S&P	500	11.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth F Momentum D VGM

Industry Rank:

Top 19% (47 out of 251)

Industry: Large Cap Pharmaceuticals

View All Zacks #1 Ranked Stocks

Research for MRK

Annual Key Company Metrics
Quarterly Key Company Metrics

Revenue - Line of Business Segments	YR Estimate	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Sales: Cardiovascular: Adempas [$...		255	238	252	220	215
Sales: Neuroscience: Belsomra [$M...		231	258	318	327	306
Sales: Animal Health: Livestock [...		3,337	3,300	3,295	2,939	2,784
Sales: Animal Health: Companion A...		2,288	2,250	2,273	1,764	1,609
Sales: Hospital Acute Care: Zerba...		218	169	-1	130	121
Sales: Cardiovascular: Alliance r...		367	341	342	281	204
Sales: Hospital Acute Care: Prevy...		605	428	370	281	165
Sales: Virology: Lagevrio [$M]		1,428	5,684	952	--	--
Sales: Hospital Acute Care: Dific...		302	263	175	--	--
Sales: Vaccines: Vaxneuvance [$M]		665	170	--	--	--
Sales: Pharmaceutical [$M]		53,583	52,005	42,754	36,610	41,751
Sales: Other Revenues [$M]		907	1,728	382	182	521
Sales: Virology: Isentress [$M]		483	633	769	857	975
Sales: Diabetes: Janumet [$M]		1,177	1,700	1,964	1,971	2,041
Sales: Diabetes: Januvia [$M]		2,189	2,813	3,324	3,306	3,482
Sales: Hospital Acute Care: Noxaf...		213	238	259	329	662
Sales: Diabetes: Other Pharmaceut...		2,283	2,319	2,118	2,312	696
Sales: Immunology: Remicade [$M]		187	207	299	330	411
Sales: Immunology: Simponi [$M]		710	706	825	838	830
Sales: Animal health [$M]		5,625	5,550	5,568	4,703	4,393
Sales: Oncology: Keytruda [$M]		25,011	20,937	17,186	14,380	11,084
Sales: Oncology: Alliance Revenue...		1,199	1,116	989	725	444
Sales: Oncology: Alliance revenue...		960	876	704	580	404
Sales: Oncology: Alliance revenue...		212	166	17	--	--
Sales: Vaccines: Gardasil [$M]		8,886	6,897	5,673	3,938	3,737
Sales: Vaccines: ProQuar/M-M-R II...		2,368	2,241	2,135	1,878	2,275
Sales: Vaccines: RotaTeq [$M]		769	783	807	797	791
Sales: Vaccines: Pneumovax [$M]		412	602	893	1,087	926
Sales: Vaccines - Total [$M]	--	13,654	11,297	10,132	8,257	8,368
Sales: Hospital Acute Care: Bridi...		1,842	1,685	1,532	1,198	1,131
Revenue - Geographic Segments	YR Estimate	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Sales: Hospital Acute Care: Bridi...		1,156	922	762	583	533
Sales: Diabetes: Januvia - U.S. [...		1,151	1,248	1,404	1,470	1,724
Sales: Diabetes: Janumet - U.S. [...		223	355	367	477	589
Sales: Cardiovascular: Adempas - ...		255	238	252	220	215
Sales: Neuroscience: Belsomra - U...		81	79	78	81	92
Sales: Neuroscience: Belsomra - I...		150	179	241	247	214
Sales: Animal Health: Livestock -...		700	710	667	612	582
Sales: Animal Health: Livestock -...		2,637	2,590	2,628	2,327	2,201
Sales: Animal Health: Companion A...		1,104	1,112	1,091	872	724
Sales: Animal Health: Companion A...		1,184	1,138	1,182	892	885
Sales: Hospital Acute Care: Zerba...		119	89	4	74	63
Sales: Hospital Acute Care: Zerba...		100	79	-5	56	58
Sales: Cardiovascular: Alliance r...		350	329	312	259	194
Sales: Cardiovascular: Alliance r...		16	12	30	22	10
Sales: Hospital Acute Care: Prevy...		264	188	153	119	84
Sales: Hospital Acute Care: Prevy...		341	240	218	162	81
Sales: Virology: Lagevrio - U.S. ...		10	1,523	632	--	--
Sales: Virology: Lagevrio - Inter...		1,418	4,161	320	--	--
Sales: Hospital Acute Care: Dific...		274	241	166	--	--
Sales: Hospital Acute Care: Dific...		28	22	10	--	--
Sales: Pharmaceutical - U.S. [$M]		26,539	24,989	20,401	18,010	--
Sales: Pharmaceutical - Internati...		27,044	27,016	22,353	18,600	--
Sales: Diabetes: Other pharmaceut...		688	693	841	984	--
Sales: Diabetes: Other pharmaceut...		1,596	1,628	1,275	1,328	--
Sales: Other revenues - U.S. [$M...		137	395	266	71	--
Sales: Other revenues - Internati...		770	1,333	116	111	--
Geographic Revenue: International...		31,635	32,077	26,279	21,930	--
Sales: Vaccines: Vaxneuvance - U....		561	163	--	--	--
Sales: Vaccines: Vaxneuvance - In...		103	7	--	--	--
Geographic Revenue: United States...		28,480	27,206	22,425	19,588	20,519
Sales: Virology: Isentress - Inte...		268	359	474	531	576
Sales: Diabetes: Janumet - Intern...		954	1,344	1,597	1,494	1,452
Sales: Diabetes: Januvia - Intern...		1,039	1,565	1,920	1,836	1,758
Sales: Vaccines: ProQuar/M-M-R II...		531	518	506	500	592
Sales: Vaccines: Rotateq - Intern...		276	275	334	311	284
Sales: Hospital Acute Care: Noxaf...		32	51	60	42	282
Sales: Hospital Acute Care: Noxaf...		181	187	199	287	380
Sales: Vaccines: ProQuad, M-M-R I...		1,837	1,724	1,629	1,378	1,683
Sales: Vaccines: RotaTeq - U.S. [...		493	508	473	486	506
Sales: Vaccines: Pneumovax - U.S....		127	346	547	727	679
Sales: Vaccines: Pneumovax - Inte...		285	256	346	359	247
Sales: Virology: Isentress - U.S....		215	274	294	326	398
Sales: Animal health - U.S. [$M]		1,804	1,822	1,758	1,484	1,306
Sales: Animal health - Internatio...		3,821	3,728	3,810	3,219	3,086
Sales: Hospital Acute Care: Bridi...		686	762	770	615	598
Sales: Oncology: Keytruda - U.S. ...		15,114	12,686	9,765	8,352	6,305
Sales: Oncology: Keytruda - Inter...		9,897	8,251	7,421	6,028	4,779
Sales: Oncology: Alliance revenue...		607	584	515	417	269
Sales: Oncology: Alliance revenue...		592	532	473	308	176
Sales: Oncology: Alliance revenue...		657	579	417	359	239
Sales: Oncology: Alliance revenue...		303	297	287	220	165
Sales: Oncology: Alliance revenue...		168	123	0	--	--
Sales: Oncology: Alliance revenue...		43	43	17	--	--
Sales: Vaccines: Gardasil - U.S. ...		2,083	2,065	1,881	1,755	1,831
Sales: Vaccines: Gardasil - Inter...		6,803	4,832	3,792	2,184	1,905

Revenue - Line of Business Segments	Qtr Estimate	09/30/2024	06/30/2024	03/31/2024	12/31/2023	09/30/2023
Sales: Cardiovascular: Adempas [$...		72	72	70	66	65
Sales: Neuroscience: Belsomra [$M...		78	53	46	54	58
Sales: Animal Health: Livestock [...		886	837	850	808	874
Sales: Animal Health: Companion A...		601	645	661	470	526
Sales: Hospital Acute Care: Zerba...		64	62	56	61	53
Sales: Cardiovascular: Alliance r...		102	106	98	108	92
Sales: Hospital Acute Care: Prevy...		208	188	174	175	157
Sales: Virology: Lagevrio [$M]		383	110	350	193	640
Sales: Hospital Acute Care: Dific...		96	92	73	87	74
Sales: Vaccines: Vaxneuvance [$M]		239	189	219	176	214
Sales: Pharmaceutical [$M]		14,943	14,408	14,006	13,141	14,263
Sales: Other Revenues [$M]		227	222	258	211	299
Sales: Virology: Isentress [$M]		102	89	111	105	119
Sales: Diabetes: Janumet [$M]		204	224	251	240	255
Sales: Diabetes: Januvia [$M]		278	405	419	547	581
Sales: Hospital Acute Care: Noxaf...		41	45	56	46	51
Sales: Diabetes: Other Pharmaceut...		--	573	576	595	549
Sales: Immunology: Remicade [$M]	--	41	35	39	43	45
Sales: Immunology: Simponi [$M]	--	189	172	184	171	179
Sales: Animal health [$M]		1,487	1,482	1,511	1,278	1,400
Sales: Oncology: Keytruda [$M]		7,429	7,270	6,947	6,608	6,338
Sales: Oncology: Alliance Revenue...		337	317	292	315	299
Sales: Oncology: Alliance revenue...		251	249	255	226	260
Sales: Oncology: Alliance revenue...		100	90	71	70	52
Sales: Vaccines: Gardasil [$M]		2,306	2,478	2,249	1,871	2,585
Sales: Vaccines: ProQuar/M-M-R II...		703	617	570	545	713
Sales: Vaccines: RotaTeq [$M]		193	163	216	185	156
Sales: Vaccines: Pneumovax [$M]		68	59	61	85	140
Sales: Vaccines - Total [$M]		3,509	3,656	3,424	2,962	4,002
Sales: Hospital Acute Care: Bridi...		420	455	440	429	424
Revenue - Geographic Segments	Qtr Estimate	09/30/2024	06/30/2024	03/31/2024	12/31/2023	09/30/2023
Sales: Hospital Acute Care: Bridi...		339	351	329	315	265
Sales: Diabetes: Januvia - U.S. [...		67	177	183	309	328
Sales: Diabetes: Janumet - U.S. [...		15	17	39	41	43
Sales: Cardiovascular: Adempas - ...		72	72	70	66	65
Sales: Neuroscience: Belsomra - U...		20	19	15	21	23
Sales: Neuroscience: Belsomra - I...		58	34	32	33	35
Sales: Animal Health: Livestock -...		194	168	166	158	205
Sales: Animal Health: Livestock -...		692	669	683	649	669
Sales: Animal Health: Companion A...		293	287	308	229	257
Sales: Animal Health: Companion A...		307	358	354	242	269
Sales: Hospital Acute Care: Zerba...		39	33	33	33	29
Sales: Hospital Acute Care: Zerba...		26	28	23	28	24
Sales: Cardiovascular: Alliance r...		96	98	90	102	96
Sales: Cardiovascular: Alliance r...		7	8	8	6	-4
Sales: Hospital Acute Care: Prevy...		101	90	74	78	70
Sales: Hospital Acute Care: Prevy...		107	98	100	98	87
Sales: Virology: Lagevrio - U.S. ...		84	15	45	10	0
Sales: Virology: Lagevrio - Inter...		299	95	305	183	640
Sales: Hospital Acute Care: Dific...		83	79	68	75	69
Sales: Hospital Acute Care: Dific...		13	12	5	12	5
Sales: Pharmaceutical - U.S. [$M]		8,227	7,399	6,936	6,698	7,153
Sales: Pharmaceutical - Internati...		6,717	7,009	7,070	6,443	7,110
Sales: Diabetes: Other pharmaceut...		213	190	157	144	197
Sales: Diabetes: Other pharmaceut...		426	386	419	450	353
Sales: Other revenues - U.S. [$M...		22	22	68	3	100
Sales: Other revenues - Internati...		206	200	190	208	199
Geographic Revenue: International...		7,922	8,236	8,297	7,542	8,247
Sales: Vaccines: Vaxneuvance - U....		137	99	161	138	182
Sales: Vaccines: Vaxneuvance - In...		103	90	58	38	33
Geographic Revenue: United States...		8,736	7,876	7,478	7,088	7,715
Sales: Virology: Isentress - Inte...		48	46	61	56	61
Sales: Diabetes: Janumet - Intern...		190	208	212	198	211
Sales: Diabetes: Januvia - Intern...		211	227	236	239	252
Sales: Vaccines: ProQuar/M-M-R II...		131	127	133	143	146
Sales: Vaccines: Rotateq - Intern...		62	56	67	73	48
Sales: Hospital Acute Care: Noxaf...		--	0	8	4	4
Sales: Hospital Acute Care: Noxaf...		--	44	48	43	47
Sales: Vaccines: ProQuad, M-M-R I...		572	490	438	402	567
Sales: Vaccines: RotaTeq - U.S. [...		131	107	149	112	108
Sales: Vaccines: Pneumovax - U.S....		19	11	6	22	42
Sales: Vaccines: Pneumovax - Inte...		49	48	55	62	98
Sales: Virology: Isentress - U.S....		54	43	50	50	58
Sales: Animal health - U.S. [$M]		487	455	474	387	462
Sales: Animal health - Internatio...		999	1,027	1,037	891	938
Sales: Hospital Acute Care: Bridi...		81	104	111	113	159
Sales: Oncology: Keytruda - U.S. ...		4,500	4,412	4,119	3,972	3,795
Sales: Oncology: Keytruda - Inter...		2,929	2,858	2,828	2,636	2,543
Sales: Oncology: Alliance revenue...		161	153	135	168	153
Sales: Oncology: Alliance revenue...		177	165	157	147	146
Sales: Oncology: Alliance revenue...		173	177	173	181	160
Sales: Oncology: Alliance revenue...		78	73	82	45	100
Sales: Oncology: Alliance revenue...		82	75	58	60	43
Sales: Oncology: Alliance revenue...		18	15	12	10	10
Sales: Vaccines: Gardasil - U.S. ...		1,020	536	488	365	838
Sales: Vaccines: Gardasil - Inter...		1,285	1,941	1,761	1,506	1,746

Member Sign In

Member Sign In

Services Overview

Investor Services

Other Services

Trading Services

Innovators